NCT00330707View on ClinicalTrials.gov

Combined Use of BCG and Interferon Alpha in Bladder Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 31, 1995

Study Completion Date

June 30, 2005

Conditions
Carcinoma of Urinary Bladder, Superficial
Interventions
DRUG

Bacillus Calmette Guerin and interferon alpha

Trial Locations (1)

119074

National University Hospital, Singapore

All Listed Sponsors
collaborator

National Medical Research Council (NMRC), Singapore

OTHER_GOV

lead

National University Hospital, Singapore

OTHER

NCT00330707 - Combined Use of BCG and Interferon Alpha in Bladder Cancer | Biotech Hunter | Biotech Hunter